Phase I/II Study of Ipilimumab for Patients With Metastatic Melanoma
WEBER, Jeffrey S, O'DAY, Steven, URBA, Walter, POWDERLY, John, NICHOL, Geoff, YELLIN, Michael, SNIVELY, Jolie, HERSH, Evan
Published in Journal of clinical oncology (20.12.2008)
Published in Journal of clinical oncology (20.12.2008)
Get full text
Journal Article
Autoimmunity in a Phase I Trial of a Fully Human Anti-Cytotoxic T-Lymphocyte Antigen-4 Monoclonal Antibody With Multiple Melanoma Peptides and Montanide ISA 51 for Patients With Resected Stages III and IV Melanoma
SANDERSON, Kristin, SCOTLAND, Ronald, YELLIN, Michael, WEBER, Jeffrey, LEE, Peter, DONGXIN LIU, GROSHEN, Susan, SNIVELY, Jolie, SIAN, Shirley, NICHOL, Geoffrey, DAVIS, Thomas, KELER, Tibor
Published in Journal of clinical oncology (01.02.2005)
Published in Journal of clinical oncology (01.02.2005)
Get full text
Journal Article
A Phase I Trial of SD-9427 (Progenipoietin) with a Multipeptide Vaccine for Resected Metastatic Melanoma
PULLARKAT, Vinod, LEE, Peter P, WOLFE, Richard A, WEBER, Jeffrey S, SCOTLAND, Ronaldo, RUBIO, Valerie, GROSHEN, Susan, GEE, Conway, LAU, Roy, SNIVELY, Jolie, SIAN, Shirley, WOULFE, Susan L
Published in Clinical cancer research (01.04.2003)
Get full text
Published in Clinical cancer research (01.04.2003)
Journal Article
Phase I study of intranodal delivery of a plasmid DNA vaccine for patients with Stage IV melanoma
Tagawa, Scott T., Lee, Peter, Snively, Jolie, Boswell, William, Ounpraseuth, Song, Lee, Sandra, Hickingbottom, Barbara, Smith, John, Johnson, Denise, Weber, Jeffrey S.
Published in Cancer (01.07.2003)
Published in Cancer (01.07.2003)
Get full text
Journal Article
Phase 1 trial of intranodal injection of a Melan-A/MART-1 DNA plasmid vaccine in patients with stage IV melanoma
Weber, Jeffrey, Boswell, William, Smith, John, Hersh, Evan, Snively, Jolie, Diaz, Mella, Miles, Sabrina, Liu, Xiding, Obrocea, Mihail, Qiu, Zhiyong, Bot, Adrian
Published in Journal of immunotherapy (1997) (01.02.2008)
Published in Journal of immunotherapy (1997) (01.02.2008)
Get more information
Journal Article
Paclitaxel, ifosfamide, and cisplatin (TIP) efficacy for first-line treatment of patients (pts) with intermediate- or poor-risk germ cell tumors (GCT)
Feldman, Darren Richard, Hu, James, Dorff, Tanya B., Patil, Sujata, Van Alstine, Lindsay Joy, Momen, Lamia, Carousso, Maryann, Hughes, Amanda, Snively-Solomon, Jolie, Ketchens, Charlean, Sheinfeld, Joel, Bains, Manjit S., Bajorin, Dean F., Bosl, George J., Motzer, Robert John, Quinn, David I.
Published in Journal of clinical oncology (20.05.2013)
Published in Journal of clinical oncology (20.05.2013)
Get full text
Journal Article
Phase II trial of paclitaxel, ifosfamide, and cisplatin (TIP) for previously untreated patients (pts) with intermediate- or poor-risk germ cell tumors (GCT)
Feldman, Darren Richard, Hu, James, Dorff, Tanya B., Patil, Sujata, Van Alstine, Lindsay Joy, Momen, Lamia, Carousso, Maryann, Hughes, Amanda, Snively-Solomon, Jolie, Ketchens, Charlean, Sheinfeld, Joel, Bains, Manjit S., Bajorin, Dean F., Bosl, George J., Motzer, Robert John, Quinn, David I.
Published in Journal of clinical oncology (20.02.2013)
Published in Journal of clinical oncology (20.02.2013)
Get full text
Journal Article